Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure

by Courtney Premer, PhD, Anthony J. Kanelidis, MD, Joshua M. Hare, MD, Ivonne Hernandez Schulman, MD
Published 2019-03-01

Transcriptomic Analysis Identifies the Effect of Beta-Blocking Agents on a Molecular Pathway of Contraction in the Heart and Predicts Response to Therapy

by Bettina Heidecker, MD, Michelle M. Kittleson, MD, PhD, Edward K. Kasper, MD, Ilan S. Wittstein, MD, Hunter C. Champion, MD, PhD, Stuart D. Russell, MD, Kenneth L. Baughman, MD, Joshua M. Hare, MD
Published 2016-04-01

Demographic representation in clinical trials for cell-based therapy

by Russell G. Saltzman, MSPH(c), Dushyantha T. Jayaweera, MD, Lina V. Caceres, MHS, Jairo A. Tovar, MD, Mayra Vidro-Casiano, MPH, Vela Karakeshishyan, BSN, Jeanette Soto, APRN, Aisha Khan, MSc, MBA, Raul D. Mitrani, MD, Ivonne H. Schulman, MD, Joshua M. Hare, MD
Published 2021-03-01